Cargando…
Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156905/ https://www.ncbi.nlm.nih.gov/pubmed/34052236 http://dx.doi.org/10.1016/j.kint.2021.05.006 |
| _version_ | 1783699559053000704 |
|---|---|
| author | Schwotzer, Nora Kissling, Sébastien Fakhouri, Fadi |
| author_facet | Schwotzer, Nora Kissling, Sébastien Fakhouri, Fadi |
| author_sort | Schwotzer, Nora |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8156905 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81569052021-05-28 Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” Schwotzer, Nora Kissling, Sébastien Fakhouri, Fadi Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-08 2021-05-27 /pmc/articles/PMC8156905/ /pubmed/34052236 http://dx.doi.org/10.1016/j.kint.2021.05.006 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Schwotzer, Nora Kissling, Sébastien Fakhouri, Fadi Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” |
| title | Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” |
| title_full | Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” |
| title_fullStr | Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” |
| title_full_unstemmed | Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” |
| title_short | Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine” |
| title_sort | letter regarding “minimal change disease relapse following sars-cov-2 mrna vaccine” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156905/ https://www.ncbi.nlm.nih.gov/pubmed/34052236 http://dx.doi.org/10.1016/j.kint.2021.05.006 |
| work_keys_str_mv | AT schwotzernora letterregardingminimalchangediseaserelapsefollowingsarscov2mrnavaccine AT kisslingsebastien letterregardingminimalchangediseaserelapsefollowingsarscov2mrnavaccine AT fakhourifadi letterregardingminimalchangediseaserelapsefollowingsarscov2mrnavaccine |